Compare · NAKA vs PRVA
NAKA vs PRVA
Side-by-side comparison of Nakamoto Inc. (NAKA) and Privia Health Group Inc. (PRVA): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both NAKA and PRVA operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- PRVA is the larger of the two at $3.39B, about 48.0x NAKA ($70.7M).
- Over the past year, NAKA is down 99.1% and PRVA is up 37.1% - PRVA leads by 136.2 points.
- PRVA has been more active in the news (9 items in the past 4 weeks vs 3 for NAKA).
- PRVA has more recent analyst coverage (25 ratings vs 3 for NAKA).
- Company
- Nakamoto Inc.
- Privia Health Group Inc.
- Price
- $4.10+2.76%
- $26.88-1.12%
- Market cap
- $70.7M
- $3.39B
- 1M return
- -8.48%
- +14.14%
- 1Y return
- -99.07%
- +37.14%
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2024
- 2021
- News (4w)
- 3
- 9
- Recent ratings
- 3
- 25
Privia Health Group Inc.
Privia Health Group, Inc. operates as a physician practice management and population health technology company in the United States. The company comprises regional medical groups, accountable care organizations, and specialty verticals. It offers technology and population health tools to enhance independent providers' workflows; management service organization that enables providers to reduce administrative work focus on their patients; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; physician-led accountable care organization, which engages patients, reduces inappropriate utilization, and enhances coordination and patient quality metrics to drive value-based care and transform the healthcare delivery system; and network for purchasers and payers. The company was founded in 2007 and is headquartered in Arlington, Virginia. Privia Health Group, Inc. operates as a subsidiary of Brighton Health Group Holdings, LLC.
Latest NAKA
- Clear Street Executes First Bitcoin Depositary Receipt Trade Through Prime Brokerage Platform
- Nakamoto Announces Closing of Legacy Healthcare Clinics
- Nakamoto Inc. filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits
- Nakamoto Inc. filed SEC Form 8-K: Creation of a Direct Financial Obligation, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
- Nakamoto Strengthens Capital Structure Through Debt Reduction, Refinancing, and Share Repurchase Authorization
- Amendment: SEC Form SCHEDULE 13D/A filed by Nakamoto Inc.
- Nakamoto Chairman and CEO David Bailey Purchases Additional Shares of Common Stock
- Chief Executive Officer Bailey David F bought $309,516 worth of shares (55,115 units at $5.62), increasing direct ownership by 2% to 3,175,476 units (SEC Form 4)
- Chief Executive Officer Bailey David F bought $683,112 worth of shares (136,333 units at $5.01), increasing direct ownership by 5% to 3,120,361 units (SEC Form 4)
- Nakamoto Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
Latest PRVA
- EVP & Chief Financial Officer Mountcastle David sold $588,679 worth of shares (21,275 units at $27.67) as part of a pre-agreed trading plan, decreasing direct ownership by 11% to 164,853 units (SEC Form 4)
- EVP & Chief Financial Officer Mountcastle David sold $16,542 worth of shares (600 units at $27.57) as part of a pre-agreed trading plan, decreasing direct ownership by 0.32% to 186,128 units (SEC Form 4)
- Privia Health Group Inc. filed SEC Form 8-K: Leadership Update
- Director Morris Matthew Shawn exercised 112,759 shares at a strike of $2.00 and sold $3,076,868 worth of shares (112,759 units at $27.29) as part of a pre-agreed trading plan, decreasing direct ownership by 11% to 68,188 units (SEC Form 4)
- EVP & Chief Financial Officer Mountcastle David sold $680,185 worth of shares (24,734 units at $27.50) as part of a pre-agreed trading plan, decreasing direct ownership by 12% to 186,728 units (SEC Form 4)
- Privia Health to Report Second Quarter 2026 Results on Thursday, August 6
- Director Morris Matthew Shawn exercised 135,498 shares at a strike of $2.00 and sold $3,566,335 worth of shares (135,498 units at $26.32) as part of a pre-agreed trading plan (SEC Form 4)
- Director Morris Matthew Shawn exercised 151,322 shares at a strike of $2.00 and sold $3,832,986 worth of shares (151,322 units at $25.33) as part of a pre-agreed trading plan (SEC Form 4)
- EVP & Chief Financial Officer Mountcastle David exercised 17,196 shares at a strike of $2.00 and sold $432,995 worth of shares (17,196 units at $25.18) as part of a pre-agreed trading plan (SEC Form 4)
- Privia Health Enters New Jersey